Home › NCT06604039

A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices

A Prospective Clinical Registry Evaluating Safety and Performance of Teleflex Vascular Access Devices

Who can join

All ages · All sexes

Inclusion Criteria:

* Subjects will undergo a procedure that will include use of a Teleflex device covered by this Research.
* Subject is willing and capable of providing informed consent and/or give approval to collect, store and process limited health information by the Sponsor; or such consent is provided by a legally designated representative if required by local law or regulation.
* Subjects is able to read and understand English or Spanish languages

Exclusion Criteria:

* Subject is currently participating in another clinical Registry or investigation that may confound the results of this Registry.
* Subject was previously failed screening or was enrolled in this clinical Registry.
* Subject is imprisoned
* Subject is cognitively impaired and unable to provide informed consent

About the study

The general objective of Teleflex's Vascular Access Device Registry (VADER) is to provide high-quality Level 3 (or better) data on the performance, safety and clinical benefits of Teleflex's vascular access devices when used in a real-world setting

What is being tested

• Central venous catheter (device)

Sponsor: Teleflex · Participants: 2,500 · Started: Dec 8, 2024

Contact the study team

• Samson Odeyemi · Phone: 9402904684
• Maame E. Sekyere · Phone: 3014012791

Official record on ClinicalTrials.gov — NCT06604039

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.